Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Jun 29, 2018 $15.92 $17.84 $15.60 $15.60 95 543
Jun 28, 2018 $18.34 $19.29 $15.62 $15.80 89 209
Jun 27, 2018 $21.64 $21.83 $18.00 $18.48 51 073
Jun 26, 2018 $19.89 $22.53 $18.61 $21.76 44 682
Jun 25, 2018 $21.49 $21.72 $18.50 $19.75 96 579
Jun 22, 2018 $23.88 $24.57 $21.50 $21.62 53 767
Jun 21, 2018 $22.29 $25.01 $21.50 $23.17 161 110
Jun 20, 2018 $25.35 $26.48 $21.40 $22.55 110 051
Jun 19, 2018 $21.35 $27.02 $21.35 $25.60 183 668
Jun 18, 2018 $18.13 $22.39 $18.06 $21.43 77 224
Jun 15, 2018 $18.70 $19.00 $18.05 $18.80 44 321
Jun 14, 2018 $17.82 $19.70 $17.82 $18.70 69 874
Jun 13, 2018 $17.98 $19.21 $17.40 $18.92 84 076
Jun 12, 2018 $17.52 $18.74 $17.40 $17.61 20 693
Jun 11, 2018 $18.74 $19.87 $17.04 $17.31 38 925
Jun 08, 2018 $19.00 $19.17 $18.05 $18.76 37 853
Jun 07, 2018 $16.53 $19.30 $16.51 $19.30 24 745
Jun 06, 2018 $17.45 $17.96 $16.84 $17.44 20 414
Jun 05, 2018 $17.25 $18.00 $17.00 $17.25 19 372
Jun 04, 2018 $19.94 $19.94 $16.80 $17.50 58 078
Jun 01, 2018 $17.63 $19.95 $17.28 $19.65 123 944
May 31, 2018 $16.61 $17.80 $16.55 $17.49 75 635
May 30, 2018 $16.00 $16.57 $15.82 $16.50 186 455
May 29, 2018 $14.94 $16.73 $14.78 $16.12 141 240
May 25, 2018 $15.21 $15.73 $14.70 $15.00 169 726
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT